| 전체보기 한의약융합데이터센터 (251)건 | ||||
| 근거중심한의약 DB | ||||
|
[무작위배정 비교임상연구] Am J Chin Med. 2014
Chinese Herbal Medicine for Obesity: A Randomized, Double-Blinded, Multicenter, Prospective Trial.
비만은 세계적으로 심각한 문제이며, 심장질환, 고혈압, 당뇨 등의 질환과 관련이 깊고, 특히 인슐린 저항성을 증가시켜 여러 가지 합병증을 일으킵니다 [1-3]. 그런데 현재까지 시장에 나와 있는 양약은 체중감소 효과가...
|
||||
| [무작위배정 비교임상연구] Am J Chin Med. 2005 Anti-hypertensive Effect of Chunghyul-dan(Qingxue-dan) on Stroke Patients with Essential Hypertension. | ||||
| 약물상호작용 DB | ||||
|
[한약-양약 상호작용]
1.
[Interaction] In male SD rats given a single oral dose of ondansetron (10 mg/kg) with Ijintang-gamibang (IJTGMB, 100 mg/kg) co-administered orally within 5 min, the plasma concentration profile of ondans ... ...: Omni Herb(영천) 약재로 제조한 물 추출물 (동결 건조)
구성: 반하 16, 진피 8, 복령 8, 창출 8, 신곡 8, 맥아 8, 황련 8, 감초 4 (총 68 g) * 이진탕 (반하·진피·복령·감초)에 창출·신곡·맥아·황련을 가한 가미방 Treatment: 100 mg... |
||||
|
[한약-양약 상호작용]
[Interaction]
In a rat model of oral ulcerative mucositis (OUM) induced by 5-fluorouracil (40 mg/kg i.p., three times at 2-day intervals) followed by 50% acetic acid application, oral administration of 1% hangesha ... ... 유도함.
[한약투여조건] Material: HST 엑스 분말 (Tsumura & Co.) 구성: 반하, 황금, 건강, 인삼, 감초, 대조, 황련 (7종) Treatment: 1% HST 함유 분말사료 자유 섭취 (초산 처치일부터 실험 종료까지) ※ 약동학 시험에서는 0.9~1.1 g... |
||||
| 생약 up-to-date | ||||
|
|
||||
|
|
| 전체보기 지식솔루션센터 (7)건 |
| 생활 속 한의 |
| 전체보기 사이언스센터 (3)건 |
| 한의약 과학 한마당 |
| 한의학 뉴스 |
|
식품금지원료 '시호·황련' 사용 건기식업체 적발
데일리팜 2014-02-13
명성사, 인삼성분 함유 미삼정 회수
|
|
3년간 한약치료로 내당능장애 환자 당뇨발병률, 대조군의 절반
민족의학신문 2013-12-05
3년간 한약치료로 내당능장애 환자 당뇨발병률, 대조군의 절반
|
| 근거중심한의약 DB |
|
[무작위배정 비교임상연구] Am J Chin Med. 2014
Chinese Herbal Medicine for Obesity: A Randomized, Double-Blinded, Multicenter, Prospective Trial.
비만은 세계적으로 심각한 문제이며, 심장질환, 고혈압, 당뇨 등의 질환과 관련이 깊고, 특히 인슐린 저항성을 증가시켜 여러 가지 합병증을 일으킵니다 [1-3]. 그런데 현재까지 시장에 나와 있는 양약은 체중감소 효과가...
|
| [무작위배정 비교임상연구] Am J Chin Med. 2005 Anti-hypertensive Effect of Chunghyul-dan(Qingxue-dan) on Stroke Patients with Essential Hypertension. |
| 약물상호작용 DB | ||||
|
[한약-양약 상호작용]
1.
[Interaction] In male SD rats given a single oral dose of ondansetron (10 mg/kg) with Ijintang-gamibang (IJTGMB, 100 mg/kg) co-administered orally within 5 min, the plasma concentration profile of ondansetron did not differ from the control, and none of the pharmacokinetic parameters (Tmax, Cmax, AUC, t1/2, MRTinf) differed between the two treatments. The same was true for the initial dose of the repeated-dosing study after 6 days of IJTGMB pretreatment [2]. [Expert interpretation] Ijintang-gamibang does not affect the pharmacokinetics of Ondansetron on single co-administration, as it alters neither the absorption nor the elimination of Ondansetron, with or without 6-day pretreatment. 2. [Interaction] After 8 days of repeated co-administration (following 6 days of IJTGMB pretreatment), plasma ondansetron was detected at lower concentrations and for a longer duration in the combination group than in the control. AUC0-t decreased from 460.82 +- 150.84 to 281.15 +- 60.21 ng*h/mL and AUC0-inf from 473.32 +- 164.17 to 291.54 +- 59.10 ng*h/mL (both p<0.05); Cmax fell from 327.60 +- 57.35 to 237.60 +- 72.96 ng/mL, while t1/2 (0.66 -> 0.78 h) and MRTinf (1.35 -> 1.33 h) were largely unchanged [2]. [Expert interpretation] Repeated co-administration of Ijintang-gamibang significantly reduces the bioavailability of Ondansetron by interfering with its absorption while leaving t1/2 and MRTinf unchanged; the authors suggest separating the two by an interval longer than the MRTinf of Ondansetron. ...: Omni Herb(영천) 약재로 제조한 물 추출물 (동결 건조)
구성: 반하 16, 진피 8, 복령 8, 창출 8, 신곡 8, 맥아 8, 황련 8, 감초 4 (총 68 g) * 이진탕 (반하·진피·복령·감초)에 창출·신곡·맥아·황련을 가한 가미방 Treatment: 100 mg... |
||||
|
[한약-양약 상호작용]
[Interaction]
In a rat model of oral ulcerative mucositis (OUM) induced by 5-fluorouracil (40 mg/kg i.p., three times at 2-day intervals) followed by 50% acetic acid application, oral administration of 1% hangeshashinto (HST) in the diet significantly lowered the OUM score on days 6 and 7 after acetic acid treatment and significantly increased body weight on day 6 (274.3+-7.7 g vs 260.7+-6.7 g). Pharmacokinetic analysis showed that plasma concentrations of the active ingredients after oral HST were below the effective concentrations for keratinocyte migration, suggesting a direct local action of HST on the oral mucosa rather than a systemic one [1]. [Expert interpretation] Banhasasimtang accelerates the healing of 5-FU-induced oral ulcerative mucositis through direct local action at the ulcer site rather than systemic exposure, as plasma levels of its active ingredients remain below the concentrations effective for keratinocyte migration. ... 유도함.
[한약투여조건] Material: HST 엑스 분말 (Tsumura & Co.) 구성: 반하, 황금, 건강, 인삼, 감초, 대조, 황련 (7종) Treatment: 1% HST 함유 분말사료 자유 섭취 (초산 처치일부터 실험 종료까지) ※ 약동학 시험에서는 0.9~1.1 g... |
| 생약 up-to-date |
|
|
|
|
| 생활 속 한의 |
| 한의약 과학 한마당 |







